The inaugural Anti-Inflammatories: Small Molecule Approaches event, held in San Diego as part of CHIs Fifth Annual Drug Discovery Chemistry convention, included topics covering new therapeutic developments in the field of anti-inflammatory research. This conference report highlights selected presentations on the JAK family of kinases, Btk inhibitors, thyroid hormone analogs, CRAC channel targets, histamine H4 receptor antagonists, and immunoproteasome-LMP7 selective inhibitors. Investigational drugs discussed include tasocitinib (Pfizer Inc), ruxolitinib (Incyte Corp/Novartis AG), INCB-28050 (Incyte Corp/Eli Lilly & Co), AVL-292 (Avila Therapeutics Inc), PCI-32765 (Pharmacyclics Inc), the naproxen analog ATB-346 (Antibe Therapeutics Inc), JNJ-28307474 (Johnson & Johnson Pharmaceutical Research & Development LLC/Abbott Laboratories), ONX-0914 (Onyx Pharmaceuticals Inc) and CPSI-2364 (Cytokine PharmaSciences Inc).
Anti-Inflammatories: Small Molecule Approaches - CHI's Inaugural / P. Seneci. - In: IDRUGS. - ISSN 1369-7056. - 13:6(2010), pp. 379-382.
Titolo: | Anti-Inflammatories: Small Molecule Approaches - CHI's Inaugural |
Autori: | |
Settore Scientifico Disciplinare: | Settore CHIM/06 - Chimica Organica Settore BIO/14 - Farmacologia |
Data di pubblicazione: | 2010 |
Rivista: | |
Tipologia: | Article (author) |
Appare nelle tipologie: | 01 - Articolo su periodico |